Showing results (271-280 of 731) with videos related to

Sort By:
Pageof 74
Translational Oncology|July 4, 2017
Contrast-Enhanced CT Density Predicts Response to Sunitinib Therapy in Metastatic Renal Cell Carcinoma PatientsSimon Matoori, Yeeliang Thian, Dow-Mu Koh, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2015
Prognostic score for patients with advanced melanoma treated with ipilimumabStefan Diem, Benjamin Kasenda, Juan Martin-Liberal, et al.
BMC Primary Care|February 27, 2025
How do people with multimorbidity prioritise healthcare when faced with tighter financial constraints? A national survey with a choice experiment componentJames Larkin, Louise Foley, Shane Timmons, et al.
Radiology|May 30, 2014
Revised Choi imaging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinibYeeliang Thian, Andreas Gutzeit, Dow-Mu Koh, et al.
Acta Oncologica (Stockholm, Sweden)|March 21, 2006
Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumabThomas Yau, Charles Swanton, Sue Chua, et al.
Pigment Cell & Melanoma Research|May 15, 2012
Genomic characterisation of acral melanoma cell linesSimon J Furney, Samra Turajlic, Kerry Fenwick, et al.
Nature Genetics|February 4, 2014
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencingMarco Gerlinger, Stuart Horswell, James Larkin, et al.
Breast Cancer Research and Treatment|March 19, 2013
A 3-gene proliferation score (TOP-FOX-67) can re-classify histological grade-2, ER-positive breast cancers into low- and high-risk prognostic categoriesBorbala Szekely, Takayuki Iwamoto, A Marcell Szasz, et al.
Histopathology|May 3, 2022
An introduction to the WHO 5th edition 2022 classification of testicular tumoursDaniel M Berney, Ian Cree, Vishal Rao, et al.
Histopathology|August 9, 2022
What's new in WHO fifth edition - urinary tractEva Compérat, Mahul B Amin, Dan M Berney, et al.
Pageof 74